FDA Nominee Deflects Senate Inquiries Regarding Scientific Autonomy and Tobacco Lobbying

By Beth Mole · Ars Technica · 2026-09-25

Ars Technica reports that FDA commissioner nominee Overton faced intense questioning from senators over her refusal to challenge the administration's medical assertions. During her confirmation hearing, she declined to label executive claims about vaccines and autism as incorrect

Ars Technica reports that FDA commissioner nominee Overton faced intense questioning from senators over her refusal to challenge the administration's medical assertions. During her confirmation hearing, she declined to label executive claims about vaccines and autism as incorrect